Y200-2785 Screening compound: N-(6-bromo-1,3-benzothiazol-2-yl)furan-2-carboxamide

Y200-2785 Screening compound: N-(6-bromo-1,3-benzothiazol-2-yl)furan-2-carboxamide
Y200-2785 Screening compound: N-(6-bromo-1,3-benzothiazol-2-yl)furan-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-2785
N-(6-bromo-1,3-benzothiazol-2-yl)furan-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-2785

Molecular Formula

C12H7BrN2O2S (C12 H7 BrN2 O2 S)

Compound Name

N-(6-bromo-1,3-benzothiazol-2-yl)furan-2-carboxamide

IUPAC name

N-(6-bromo-13-benzothiazol-2-yl)furan-2-carboxamide

SMILES

O=C(c1ccco1)Nc1nc(ccc(Br)c2)c2s1

InChI

InChI=1S/C12H7BrN2O2S/c13-7-3-4-8-10(6-7)18-12(14-8)15-11(16)9-2-1-5-17-9/h1-6H,(H,14,15,16)

InChI Key

VSQWPWFIMGAUPU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02657701

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

323.17

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.889

Distribution Coefficient, logD

3.889

Water Solubility, LogSw

-4.08

Polar Surface Area

41.669

Acid Dissociation Constant (pKa)

10.27

Base Dissociation Constant (pKb)

-1.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y200-2785 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Antiparasite Library (23996 compounds)

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Human Proteases Annotated Library (2868 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic
Agro:
  • Agro

References: we are preparing a list of scientific research reports with Y200-2785 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-2785?
Check Price and Availability of Y200-2785, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-2785 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-2785
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-2785
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-2785 available by request